Prof. Dr. Aytaç Çetinkaya Diabetic Foot Istanbul

Prof. Dr. Aytaç Çetinkaya

Specialist in Infectious Diseases and Clinical Microbiology. Diabetic foot infection, orthopedic infection and chronic wound assessment.

Last updated:

Prof. Dr. Aytaç Çetinkaya

Prof. Dr. Aytaç Çetinkaya is a specialist in Infectious Diseases and Clinical Microbiology. The main areas of work are diabetic foot infection, orthopedic infection, skin and soft tissue infection and rational antibiotic use, with patients from Istanbul, across Türkiye and from abroad.

Education

  • 1999: Medical degree, Gülhane Military Medical Academy (GATA)
  • 2006: Specialty in Infectious Diseases and Clinical Microbiology, Gülhane Military Medical Academy
  • 2016: Master's degree (with thesis) in Blood Banking and Transfusion Medicine, Gülhane Institute of Health Sciences

Academic titles

  • 2015: Assistant Professor
  • 2020: Associate Professor
  • 2024: Professor

Positions

Years Position
2000–2002 General practitioner, compulsory service (Hozat, Tunceli)
2002–2006 Residency in Infectious Diseases and Clinical Microbiology, Gülhane Military Medical Academy
2006–2012 Infectious diseases specialist, Derince Military Hospital (Kocaeli)
2006–2012 Acıbadem Kocaeli Hospital
2012–2014 Physician in charge, GATA Blood Bank, Immunohematology and Blood Components Laboratory
2014–2015 Isparta Military Hospital
2015–2016 Assistant Professor, GATA Haydarpaşa Training Hospital, Infectious Diseases Service
2015–2020 Assistant Professor, University of Health Sciences, Sultan Abdülhamid Han Training and Research Hospital (Istanbul), Department of Infectious Diseases
2020–2023 Associate Professor, University of Health Sciences, Hamidiye Faculty of Medicine, Department of Infectious Diseases

Areas of interest

  • Diabetic foot infection
  • Orthopedic infection and bone and joint infection
  • Skin and soft tissue infection
  • Rational antibiotic use and antibiotic resistance
  • Intensive care infections, fungal infections, viral hepatitis, HIV

Approach

In a diabetic foot, blood sugar, circulation, nerve damage, infection and wound care must be considered together. The aim is to preserve the limb with appropriate, timely treatment. Even when an amputation is needed, timing and level matter, so a comprehensive assessment is recommended before a decision is made.

Selected publications

A selection of papers in peer-reviewed, internationally indexed journals. The name appears in publications as "Cetinkaya RA" (Rıza Aytaç Çetinkaya).

  1. Cetinkaya RA, Yenilmez E, Petrone P, Yilmaz S, Bektore B, Simsek B, Kula Atik T, Ozyurt M, Unlu A. Platelet-rich plasma as an additional therapeutic option for infected wounds with multi-drug resistant bacteria: in vitro antibacterial activity study. Eur J Trauma Emerg Surg. 2019;45(3):555-565. PubMed
  2. Cetinkaya RA, Yilmaz S, Unlu A, Petrone P, Marini C, Karabulut E, Urkan M, Kaya E, Karabacak K, Uyanik M, Eker I, Kilic A, Gunal A. The efficacy of platelet-rich plasma gel in MRSA-related surgical wound infection treatment: an experimental study in an animal model. Eur J Trauma Emerg Surg. 2018;44(6):859-867. PubMed
  3. Ege T, Unlu A, Tas H, Bek D, Turkan S, Cetinkaya A. Reliability of the mangled extremity severity score in combat-related upper and lower extremity injuries. Indian J Orthop. 2015;49(6):656-60. PubMed
  4. Sarikaya B, Cetinkaya RA, Ozyigitoglu D, Isik SA, Kaplan M, Kirkik D, Gorenek L. High antibiotic resistance rates in Helicobacter pylori strains in Turkey over 20 years: implications for gastric disease treatment. Eur J Gastroenterol Hepatol. 2024;36(5):545-553. PubMed
  5. Kose S, Dal T, Cetinkaya RA, Ari O, Yenilmez E, Temel EN, et al. Molecular epidemiological investigation of carbapenem resistant Klebsiella pneumoniae isolated from intensive care unit patients of six geographical regions of Turkey. J Infect Dev Ctries. 2023;17(10):1446-1451. PubMed
  6. Isik SA, Yenilmez E, Cetinkaya RA, Gorenek L, Kose S. A meta-analysis of antibiotic resistance rates in Pseudomonas aeruginosa isolated in blood cultures in Turkey between 2007 and 2017. North Clin Istanb. 2021;8(3):286-297. PubMed
  7. Okumus N, Demirturk N, Cetinkaya RA, Guner R, Avci IY, Orhan S, et al. Evaluation of the effectiveness and safety of adding ivermectin to treatment in severe COVID-19 patients. BMC Infect Dis. 2021;21(1):411. PubMed
  8. Yenilmez E, Cetinkaya RA, Tural E. Diagnostic Dilemma for Low Viremia with Significant Fibrosis; is Hepatitis B Virus DNA Threshold Level a Good Indicator for Predicting Liver Damage? Balkan Med J. 2018;35(4):326-332. PubMed
  9. Unlu A, Cetinkaya RA, Ege T, Ozmen P, Hurmeric V, Ozer MT, Petrone P. Role 2 military hospitals: results of a new trauma care concept on 170 casualties. Eur J Trauma Emerg Surg. 2015;41(2):149-55. PubMed
  10. Cetinkaya RA, Gorenek L, Coskun O, Eyigun CP, Senses Z, Ide T, Kilic S. The effect of methylprednisolone on treatment in rats with induced sepsis. Clin Exp Med. 2009;9(1):45-50. PubMed

Academic profiles

More

The doctor's personal website has articles, patient stories and videos: aytaccetinkaya.com.

This page is for general information only and does not replace an examination, diagnosis or treatment. In an emergency, call your local emergency number or go to the nearest emergency department.

Message on WhatsApp